SA

Sharad Ashok Galave

Active Director Additional Director DIN 11563147
DIN 11563147 First appointment Feb 2026 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharad Ashok Galave

Data last updated:

Sharad Ashok Galave is an Additional Director at Synthlife Pharma Private Limited (since 2026). The company operates in Paper.

DIN 11563147
Primary Designation Additional Director
Industry Paper
First Appointment 21 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synthlife Pharma Private Limited U21002PN2024PTC235858
Additional Director21 Feb 2026Active

Board colleagues of Sharad Ashok Galave

Directorship timeline

Open interactive timeline →
Synthlife Pharma Private Limited
Premium access

Shareholding and investment profile for Sharad Ashok Galave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Ashok Galave

Sharad Ashok Galave currently holds 1 directorship: Synthlife Pharma Private Limited (Additional Director, since 21 Feb 2026).

Sharad Ashok Galave was first appointed on 21 Feb 2026 as Additional Director at Synthlife Pharma Private Limited.

The current boards of Sharad Ashok Galave's companies include Aparna Ashok Sawant (Synthlife Pharma Private Limited), Ashish Appasaheb Takawale (Synthlife Pharma Private Limited), Sahil Sunil Adsul (Synthlife Pharma Private Limited), Yashraj Sanjay Sawant (Synthlife Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available